Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

Affiliations

• ¹ Canada's Michael Smith Genome Sciences Center, BC Cancer Agency, Vancouver, BC V5Z 4S6, Canada.
• ² Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
• ³ Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
• ⁴ PSMAR-IMIM Lab, Bladder Cancer Center, Department of Medicine, Dana-Farber Cancer Institute and Harvard University, Boston, MA 02215, USA.
• ⁵ Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard University, Boston, MA 02115, USA.
• ⁶ Center for Epigenetics, Van Andel Research Institute, Grand Rapids, MI 49503, USA.
• ⁷ Department of Genetics, Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA.
• ⁸ Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
• ⁹ Bioinformatics and Systems Biology Laboratory, Federal University of Paraná Polytechnic Center, Curitiba, PR CEP 80.060-000, Brazil.
• ¹⁰ Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC 27709, USA.
• ¹¹ Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
• ¹² Department of Pathology, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
• ¹³ Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
• ¹⁴ Biostatistics and Computational Biology Laboratory, Department of Statistics, University of Campinas, São Paulo, 13.083-859, Brazil.
• ¹⁵ Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
• ¹⁶ Integrative Bioinformatics Support Group, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC 27709, USA.
• ¹⁷ Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
• ¹⁸ Biospecimen Core Resource, The Research Institute at Nationwide Children's Hospital, Columbus, OH 43205, USA.
• ¹⁹ Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
• ²⁰ Pathology and Medical Oncology, Dana-Farber Cancer Institute and Harvard University, Boston, MA 02115, USA.
• ²¹ Greenberg Bladder Cancer Institute, Johns Hopkins University, Baltimore, MD 21218, USA.
• ²² Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 USA. Electronic address: jweinste@mdanderson.org.
• ²³ Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Electronic address: dk@rics.bwh.harvard.edu.
• ²⁴ Scott Department of Urology, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address: slerner@bcm.edu.